Bristol’s New Products Meet Early Launch Expectations

Even So, Currency Changes Lead To Lowered Revenue Guidance

SECOND QUARTER text on a sticker on notebook, wooden background
Bristol's Q2 revenue of $11.89bn exceeded analyst consensus • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip